93983-14-3Relevant articles and documents
New derivatives of 3,4-dihydroisoquinoline-3-carboxylic acid with free-radical scavenging, d-amino acid oxidase, acetylcholinesterase and butyrylcholinesterase inhibitory activity
Solecka, Jolanta,Guspiel, Adam,Postek, Magdalena,Ziemska, Joanna,Kawcki, Robert,Lczycka, Katarzyna,Osior, Agnieszka,Pietrzak, Bartlomiej,Pypowski, Krzysztof,Wyrzykowska, Agata
, p. 15866 - 15890 (2015/01/08)
A series of 3,4-dihydroisoquinoline-3-carboxylic acid derivatives were synthesised and tested for their free-radical scavenging activity using 2,2-diphenyl-1-picrylhydrazyl radical (DPPH?), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical (ABTS?+), superoxide anion radical (O2-) and nitric oxide radical (?NO) assays. We also studied D-amino acid oxidase (DAAO), acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activity. Almost each of newly synthesised compounds exhibited radical scavenging capabilities. Moreover, several compounds showed moderate inhibitory activities against DAAO, AChE and BuChE. Compounds with significant free-radical scavenging activity may be potential candidates for therapeutics used in oxidative-stress-related diseases.
Synthesis and Renal Vasodilator Activity of 2-Chlorodopamine and N-Substituted Derivatives
McCarthy, James R.,McCowan, Jefferson,Zimmerman, Mark B.,Wenger, Marcia A.,Emmert, Lee W.
, p. 1586 - 1590 (2007/10/02)
A four-step synthesis of 2-chlorodopamine (2b) is presented as well as methods for the syntheses of the N-methyl, ethyl, and n-propyl analogues (2c-e).Compounds 2b and 2c were essentially equipotent to dopamine for increasing renal blood flow in anesthesized dogs that had been treated with the α-adrenergic antagonist phenoxybenzamine.The increases in renal blood flow were blocked by the DA1 antagonist (R)-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine.Compounds 2d and 2e were significantly less potent than dopamine in the same model; the increases in renal blood flow were attenuated by propanolol and blocked by a combination of propanolol and (R)-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine.The significance of an o-chloro substituent on dopamine analogues for the activation of the DA1 receptor is briefly discussed.